| Literature DB >> 30125325 |
Rock Bum Kim1, Minji Kim2, Yoon Young Cho2, Soo Kyoung Kim2, Jung Hwa Jung2,3, Jaehoon Jung3,4, Chi Yeon Kim3,5, Dawon Kang3,6, Jong Ryeal Hahm2,3,7.
Abstract
We examined the changes in thyroid hormone levels in patients with an acute clinical condition and compared these to levels in the healthy subjects. Serum total triiodothyronine (T3), thyroid stimulating hormone (TSH), and free thyroxine (fT4) measurements were recorded from 555 patients (mean age: 55.0 years, men: 65.9%) admitted to the emergency department (ED) 1-91 months (median: 34 months) after a regular health examination (HE). Serological data were analyzed; mean change in hormone levels was stratified by emergency classification system and quintiles of changes in inflammatory marker values, such as neutrophil lymphocyte ratio (NLR) and high-sensitivity C-reactive protein (CRP). The mean decrease in T3 levels from HE and ED samples was 10.6 ng/dL (p< 0.001). Mean decrease in T3 levels was 21.6 ng/dL among patients classified as having an infection status and 11.0 ng/dL among patients classified as having an urgency status. A decrease 3.7 ng/dL among emergency patients was observed. TSH and fT4 levels did not change across all groups. When patients were stratified into quintiles according to changes in NLR values, mean decreases in T3 were 6.21, 8.14, 14.37, 12.76, and 21.98 ng/dL and showed significant linear reduction (p<0.001). For quintiles of changed CRP values, mean decreased T3 levels were 10.57, 3.05, 4.47, 7.68, and 28.07 ng/dL. TSH and fT4 were not associated with significant changes (p = 0.100, p = 0.561, respectively). In this study, thyroid function changes in individuals with an acute condition revealed that T3 significantly decreased, more markedly in infectious diseases compared to their healthy counterparts, and decline in T3 measurements correlated with inflammatory markers. TSH and fT4 levels remained stable. It is necessary to consider the severity of acute conditions when abnormal T3 levels are detected in subjects with emergent status.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30125325 PMCID: PMC6101387 DOI: 10.1371/journal.pone.0202422
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Participant characteristics and laboratory test results at the health examination and on emergency department admission.
| N | Health examination, mean (±SD) | Emergency Department, mean (±SD) | ||
|---|---|---|---|---|
| Male, % | 555 | 65.9% | ||
| Age, years | 555 | 55.0 (±11.5) | ||
| WBC, 103cells/ mm3 | 555 | 6.3 (±1.9) | 8.3 (±3.6) | <0.001 |
| RBC, 106 cells/ mm3 | 555 | 4.7 (±0.5) | 4.5 (±0.6) | <0.001 |
| Hemoglobin, g/dL | 555 | 14.4 (±1.6) | 13.8 (±1.8) | <0.001 |
| Hematocrit, % | 555 | 42.8 (±4.4) | 40.4 (±5.0) | <0.001 |
| Platelet, 103 cells/ mm3 | 555 | 255.9 (±66.5) | 240.4 (±71.0) | <0.001 |
| ESR, mm/h | 291 | 14.5 (±13.5) | 18.2 (±21.2) | 0.001 |
| Hs-CRP, mg/L | 398 | 2.1 (±10.0) | 12.2 (±37.5) | <0.001 |
| NLR | 555 | 1.7 (±1.0) | 3.2 (±3.8) | <0.001 |
| Glucose, mg/dL | 300 | 93.3 (±23.3) | 141.0 (±63.5) | <0.001 |
| HbA1c, % | 357 | 5.9 (±0.9) | 6.0 (±1.2) | 0.004 |
| Total cholesterol, mg/dL | 349 | 192.1 (±35.1) | 176.0 (±39.8) | <0.001 |
| Triglyceride, mg/dL | 413 | 141.2 (±88.2) | 154.6 (±133.7) | 0.031 |
| HDL cholesterol, mg/dL | 402 | 51.6 (±14.1) | 48.4 (±14.6) | <0.001 |
| LDL cholesterol, mg/dL | 402 | 120.9 (±33.1) | 113.1 (±37.5) | <0.001 |
| ALP, U/L | 301 | 67.5 (±18.3) | 78.3 (±104.3) | 0.067 |
| AST, U/L | 301 | 25.8 (±13.5) | 40.4 (±60.1) | <0.001 |
| ALT, U/L | 301 | 26.2 (±18.6) | 34.3 (±50.1) | 0.005 |
| BUN, mg/dL | 300 | 15.1 (±4.7) | 15.6 (±7.3) | 0.155 |
| Creatinine, mg/dL | 299 | 0.8 (±0.2) | 0.9 (±0.6) | 0.004 |
| CK-MB, ng/mL | 252 | 117.8 (±125.8) | 240.1 (±712.1) | 0.008 |
| LDH, u/L | 257 | 184.2 (±35.0) | 243.6 (±297.8) | 0.001 |
| T3, ng/dL | 517 | 111.0 (±18.7) | 100.4 (±23.7) | <0.001 |
| TSH, mlU/L | 524 | 2.1 (±1.3) | 2.2 (±1.8) | 0.204 |
| fT4,ng/dL | 517 | 1.3 (±0.2) | 1.3 (±0.3) | 0.929 |
Abbreviations: WBC, white blood cell; RBC, red blood cell; ESR, erythrocyte sedimentation rate; NLR, neutrophil to lymphocyte ratio; CRP, C-reactive protein; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; LDL, low density lipoprotein; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; CK-MB, creatine kinase-muscle/brain; LDH, lactate dehydrogenase; T3, triiodothyronine; TSH, thyrotropin; fT4, free thyroxine.
Means of difference between health status and emergency disease status by classification.
| Infection patients (N = 32) | Emergency class patients (N = 63) | Urgency class patients (N = 460) | ||||
|---|---|---|---|---|---|---|
| Mean Difference | Mean Difference | Mean Difference | ||||
| WBC, 103cells/ mm3 | 3.9 | < 0.001 | 3.9 | < 0.001 | 1.5 | < 0.001 |
| RBC, 106 cells/ mm3 | -0.5 | < 0.001 | -0.1 | 0.100 | -0.2 | < 0.001 |
| Hemoglobin, g/dL | -1.8 | < 0.001 | -0.2 | 0.470 | -0.5 | < 0.001 |
| Hematocrit, % | -5.7 | < 0.001 | -1.5 | 0.013 | -2.4 | < 0.001 |
| Platelet, 103 cells/ mm3 | -42.1 | 0.006 | -10.8 | 0.029 | -14.3 | < 0.001 |
| ESR, mm/h | 34.0 | < 0.001 | -1.5 | 0.268 | 0.8 | 0.464 |
| Hs-CRP, mg/L | 75.7 | < 0.001 | 4.2 | 0.010 | 6.7 | < 0.001 |
| NLR | 5.5 | < 0.001 | 1.5 | < 0.001 | 1.2 | < 0.001 |
| Glucose, mg/dL | 51.5 | < 0.001 | 71.5 | < 0.001 | 44.1 | < 0.001 |
| HbA1c, % | 0.4 | 0.186 | 0.1 | 0.455 | 0.1 | 0.015 |
| Total cholesterol, mg/dL | -40.3 | 0.001 | -8.9 | 0.180 | -15.3 | < 0.001 |
| Triglyceride, mg/dL | -18.8 | 0.188 | 9.3 | 0.433 | 15.5 | 0.032 |
| HDL cholesterol, mg/dL | -1.7 | 0.533 | -1.5 | 0.220 | -3.6 | < 0.001 |
| LDL cholesterol, mg/dL | -31.0 | 0.003 | 1.6 | 0.807 | -8.2 | < 0.001 |
| ALP, U/L | 14.4 | 0.261 | 4.6 | 0.445 | 11.2 | 0.114 |
| AST, U/L | 11.4 | 0.058 | 32.7 | 0.006 | 12.5 | < 0.001 |
| ALT, U/L | 6.7 | 0.571 | 12.2 | 0.045 | 7.6 | 0.023 |
| BUN, mg/dL | 2.6 | 0.290 | -0.2 | 0.537 | 0.4 | 0.282 |
| Creatinine, mg/dL | 0.1 | 0.373 | 0.1 | 0.001 | 0.1 | 0.023 |
| CK-MB, ng/mL | 47.5 | 0.923 | 132.6 | 0.008 | 126.2 | 0.021 |
| LDH, u/L | 110.2 | 0.008 | 63.5 | 0.001 | 55.0 | 0.013 |
| T3, ng/dL | -21.6 | < 0.001 | -3.7 | 0.155 | -11.0 | < 0.001 |
| TSH, mlU/L | -0.1 | 0.966 | 0.3 | 0.639 | 0.1 | 0.298 |
| fT4,ng/dL | 0.0 | 0.512 | 0.0 | 0.950 | 0.0 | 0.800 |
Abbreviations: WBC, white blood cell; RBC, red blood cell; ESR, erythrocyte sedimentation rate; NLR, neutrophil to lymphocyte ratio; CRP, C-reactive protein; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; LDL, low density lipoprotein; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; CK-MB, creatine kinase-muscle/brain; LDH, lactate dehydrogenase; T3, triiodothyronine; TSH, thyrotropin; fT4, free thyroxine.
Fig 1Mean value of T3 levels at health examination and emergency department admission according to classification.
In infection patients (N = 32) and urgency class patients (N = 460), significantly decreased T3 levels were observed at ED compared to that at HEs; however, this was not decreased in emergency class patients (N = 63). Error bars indicate ±1 standard errors. HE = health examination, ED = emergency department.
Numbers and proportions of patients who had abnormal thyroid hormone levels by three emergency classes.
| Total patients, N (%) | Infection patients, N (%) | Emergency class patients, N (%) | Urgency class patients, N (%) | ||
|---|---|---|---|---|---|
| T3 | |||||
| Decreased from normal | 89 (17.2) | 9 (36.0) | 7 (11.7) | 73 (16.9) | 0.101 |
| Normal range (80 ~ 200 ng/dL) | 426 (82.4) | 16 (64.0) | 53 (88.3) | 357 (82.6) | |
| Increased from normal | 2 (0.4) | 0 (0.0) | 0 (0.0) | 2 (0.5) | |
| TSH | |||||
| Decreased from normal | 12 (2.3) | 1 (4.0) | 1 (1.6) | 10 (2.3) | 0.738 |
| Normal range (0.27 ~ 4.2 mlU/L) | 452 (86.3) | 20 (80.0) | 54 (88.5) | 378 (86.3) | |
| Increased from normal | 60 (11.5) | 4 (16.0) | 6 (9.8) | 50 (11.4) | |
| fT4 | |||||
| Decreased from normal | 16 (3.1) | 2 (8.0) | 2 (3.3) | 12 (2.8) | 0.262 |
| Normal range (0.93 ~ 1.7 ng/dL) | 484 (92.7) | 21 (84.0) | 56 (91.8) | 407 (93.3) | |
| Increased from normal | 22 (4.2) | 2 (8.0) | 3 (4.9) | 17 (3.9) |
Abbreviations: T3, triiodothyronine; TSH, thyrotropin; fT4, free thyroxine.
Means of differences in thyroid hormone levels between health status and emergency disease status according to quintiles of differences in inflammatory markers.
| Difference in T3, Mean (±SD) | Difference in TSH, Mean (±SD) | Difference in fT4, Mean (±SD) | |||||
|---|---|---|---|---|---|---|---|
| ESR (N = 124) | Q1 | -6.05 (±15.61) | <0.001 | 0.01 (±1.48) | 0.913 | 0.06 (±0.20) | 0.236 |
| Q2 | -4.31 (±17.12) | <0.001 | 0.01 (±1.77) | 0.338 | 0.11 (±0.37) | 0.030 | |
| Q3 | -3.30 (±20.37) | 0.10 (±1.76) | -0.01 (±0.19) | ||||
| Q4 | -17.45 (±20.46) | -0.08 (±2.90) | -0.05 (±0.25) | ||||
| Q5 | -33.50 (±25.18) | -0.28 (±2.64) | -0.07 (±0.34) | ||||
| WBC | Q1 | -9.51 (±29.09) | 0.080 | 0.01 (±1.95) | 0.284 | -0.01 (±0.24) | 0.889 |
| Q2 | -7.13 (±19.13) | 0.257 | -0.07 (±1.43) | 0.787 | -0.01 (±0.18) | 0.797 | |
| Q3 | -14.11 (±19.21) | 0.30 (±2.08) | 0.02 (±0.29) | ||||
| Q4 | -8.95 (±19.54) | 0.38 (±1.88) | -0.05 (±0.26) | ||||
| Q5 | -15.87 (±24.04) | 0.01 (±1.63) | 0.03 (±0.34) | ||||
| NLR | Q1 | -6.21 (±17.93) | <0.001 | 0.18 (±1.57) | 0.209 | -0.01 (±0.21) | 0.421 |
| Q2 | -8.14 (±16.60) | <0.001 | -0.27 (±1.55) | 0.054 | -0.03 (±0.19) | 0.310 | |
| Q3 | -14.37 (±24.65) | -0.02 (±1.45) | 0.01 (±0.21) | ||||
| Q4 | -12.76 (±20.35) | -0.07 (±1.60) | -0.01 (±0.33) | ||||
| Q5 | -21.98 (±26.13) | -0.41 (±1.93) | 0.06 (±0.36) | ||||
| CRP (N = 200) | Q1 | -10.57 (±13.99) | <0.001 | 0.00 (±1.99) | 0.100 | 0.01 (±0.21) | 0.561 |
| Q2 | -3.05 (±13.78) | <0.001 | 0.21 (±1.16) | 0.375 | 0.00 (±0.19) | 0.227 | |
| Q3 | -4.47 (±18.73) | 0.71 (±1.67) | -0.03 (±0.19) | ||||
| Q4 | -7.68 (±22.87) | -0.29 (±1.55) | 0.00 (±0.20) | ||||
| Q5 | -28.07 (±26.80) | -0.07 (±2.46) | -0.09 (±0.32) |
* The p-values mean the difference between the medians value of quintile groups resulted by Kruskal-Wallis test.
† The p-values mean the order trend of medians for quintile groups resulted by Jonckheere’s trend test.
Abbreviations: ESR, erythrocyte sedimentation rate; WBC, white blood cell; NLR, neutrophil to lymphocyte ratio; CRP, C-reactive protein; T3, triiodothyronine; TSH, thyrotropin; fT4, free thyroxine.
Fig 2Means of difference in T3 levels according to quintiles of different inflammatory markers between health status and emergency disease status.
The error bars indicate ±1 standard errors. The negative values of T3 levels represents the decrease in the emergency disease status compared to health status. Quintile values of differences in ESR are as follows: 0.00≤Q1<2.00, 2.00≤Q2<6.00, 6.00≤Q3<14.70, 14.70≤Q4<30.12, 30.12≤Q5. Differences in WBC are as follows: 0.00≤Q1< 0.75, 0.75≤Q2<1.56, 1.56≤Q3<2.58, 2.58≤Q4<4.58, 4.58≤Q5. Differences in NLR are as follows: 0.00≤Q1<0.32, 0.32≤Q2<0.77, 0.77≤Q3<1.74, 1.74≤Q4<3.86, 3.86≤Q5. Differences in CRP are as follows: 0.00≤Q1<0.10, 0.10≤Q2<0.45, 0.45≤Q3<2.07, 2.07≤Q4<20.02, 20.02≤Q5.